KRAS and colorectal cancer: Our in-vitro model demonstrates that the NDRG2 overexpression attenuates several aspects of tumorigenesis including the proliferation and invasive potential of human colorectal cancer cell line HCT116, a widely used model for KRAS mutated colorectal cancer.